The Human TOR Signaling Regulator Is the Key Indicator of Liver Cancer Patients’ Overall Survival: TIPRL/LC3/CD133/CD44 as Potential Biomarkers for Early Liver Cancers

SIMPLE SUMMARY: We recently reported that the human TOR signaling regulator (hereafter TIPRL) contributes to the drug-resistance of hepatocellular carcinomas (HCCs) and the involvement of TIPRL/LC3/CD133 in liver cancer aggressiveness. This study aims to determine prognostic and diagnostic efficacie...

Descripción completa

Detalles Bibliográficos
Autores principales: Jun, Soo Young, Yoon, Hyang Ran, Yoon, Ji-Yong, Jeon, Su-Jin, Lee, Jeong-Ju, Halder, Debasish, Kim, Jin-Man, Kim, Nam-Soon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8230774/
https://www.ncbi.nlm.nih.gov/pubmed/34208132
http://dx.doi.org/10.3390/cancers13122925

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8230774/
https://www.ncbi.nlm.nih.gov/pubmed/34208132
http://dx.doi.org/10.3390/cancers13122925

Ejemplares similares